Tectonic Therapeutic | AVRO - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Celltrion KRW 14.6B 180.89B 2025-06
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
Ionis Pharmaceuticals USD -93M 135M 2026-03
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
MacroGenics USD -14.93M 31.75M 2025-12
Medical Developments International AUD -149K 466K 2025-06
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pfizer USD 3.33B 290M 2025-09
Pharma Mar EUR 40.2M 44.28M 2025-12
Qiagen NV USD 109.17M 25.56M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Sartorius EUR 157.8M 76.1M 2026-03
Takeda JPY 133.86B 105.69B 2025-12
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06